Woodline Partners’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.71M | Hold |
500,335
| – | – | 0.02% | 576 |
|
|
2025
Q1 | $2.71M | Sell |
500,335
-1,389
| -0.3% | -$7.53K | 0.02% | 618 |
|
|
2024
Q4 | $3.74M | Buy |
501,724
+101,724
| +25% | +$758K | 0.03% | 549 |
|
|
2024
Q3 | $3.2M | Buy |
+400,000
| New | +$3.2M | 0.03% | 434 |
|
|
2024
Q2 | – | Sell |
-479,682
| Closed | -$9.92M | – | 595 |
|
|
2024
Q1 | $9.92M | Buy |
479,682
+79,682
| +20% | +$1.65M | 0.09% | 271 |
|
|
2023
Q4 | $9.24M | Buy |
+400,000
| New | +$9.24M | 0.1% | 235 |
|